You are here »
Home »
Companies » Biofil Chemicals & Pharmaceuticals Ltd - Announcements
Biofil Chemicals & Pharmaceuticals Ltd.
| BSE: 524396 |
Sector: Health care |
| NSE: BIOFILCHEM |
ISIN Code: INE829A01014 |
|
BSE
00:00 | 24 Apr 2020
|
Biofil Chemicals & Pharmaceuticals Ltd
|
|
NSE
05:30 | 01 Jan 1970
|
Biofil Chemicals & Pharmaceuticals Ltd
|
Submission Of Standalone Un Audited Financial Results For The Quarter As Well As Half Year Ended 3
November 14, 2019, 7:49 pm | Source: BSE
This is in continuation of our letter dated 6th November 2019 regarding information for Board Meeting for consideration and approval of Standalone Un-Audited Financial Results for the quarter as well as half year ended on 30th September 2019.
Pursuant to the provisions of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 we are hereby enclosing Standalone Un-Audited Financial Results for the quarter as well as half year ended 30th September 2019 duly approved by the Board of Directors of the Company at its meeting held on today i.e. Thursday 14th November 2019 together with Limited Review Report thereon in respect of unaudited financial results.
Further pursuant to Regulation 33(3)(f) and (g) of the Listing Regulations we have also. enclosed Statements of Assets and Liabilities and the Statement of Cash flow in the prescribed format for the quarter as well as half year ended 30 September 2019.
